Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-27 @ 7:20 PM
Study NCT ID:
NCT04049266
Status:
TERMINATED
Last Update Posted:
2024-07-18
First Post:
2019-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Sponsor:
Kodiak Sciences Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-06
First Submit QC Date:
None
Study First Post Date:
2019-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-04
Results First Submit QC Date:
None
Results First Post Date:
2024-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-16
Last Update Post Date:
2024-07-18
Last Update Post Date Type:
ACTUAL